Literature DB >> 27189963

Physiological Content and Intrinsic Activities of 10 Cytochrome P450 Isoforms in Human Normal Liver Microsomes.

Hai-Feng Zhang1, Huan-Huan Wang1, Na Gao1, Jun-Ying Wei1, Xin Tian1, Yan Zhao1, Yan Fang1, Jun Zhou1, Qiang Wen1, Jie Gao1, Yang-Jun Zhang1, Xiao-Hong Qian1, Hai-Ling Qiao2.   

Abstract

Due to a lack of physiologic cytochrome P450 (P450) isoform content, P450 activity is typically only determined at the microsomal level (per milligram of microsomal protein) and not at the isoform level (per picomole of P450 isoform), which could result in the misunderstanding of variations in P450 activity between individuals and further hinder development of personalized medicine. We found that there were large variations in protein content, mRNA levels, and intrinsic activities of the 10 P450s in 100 human liver samples, in which CYP2E1 and CYP2C9 showed the highest expression levels. P450 gene polymorphisms had different effects on activity at two levels: CYP3A5*3 and CYP2A6*9 alleles conferred increased activity at the isoform level but decreased activity at the microsomal level; CYP2C9*3 had no effect at the isoform level but decreased activity at the microsomal level. The different effects at each level stem from the different effects of each polymorphism on the resulting P450 protein. Individuals with CYP2A6*1/*4, CYP2A6*1/*9, CYP2C9*1/*3, CYP2D6 100C>T TT, CYP2E1 7632T>A AA, CYP3A5*1*3, and CYP3A5*3*3 genotypes had significantly lower protein content, whereas CYP2D6 1661G>C mutants had a higher protein content. In conclusion, we first offered the physiologic data of 10 P450 isoform contents and found that some single nucleotide polymorphisms had obvious effects on P450 expression in human normal livers. The effects of gene polymorphisms on intrinsic P450 activity at the isoform level were quite different from those at the microsomal level, which might be due to changes in P450 protein content.
Copyright © 2016 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27189963     DOI: 10.1124/jpet.116.233635

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  24 in total

1.  Impact of Ethnicity-Specific Hepatic Microsomal Scaling Factor, Liver Weight, and Cytochrome P450 (CYP) 1A2 Content on Physiologically Based Prediction of CYP1A2-Mediated Pharmacokinetics in Young and Elderly Chinese Adults.

Authors:  Guo-Fu Li; Qing-Shan Zheng; Yichao Yu; Wei Zhong; Hong-Hao Zhou; Furong Qiu; Guangji Wang; Guo Yu; Hartmut Derendorf
Journal:  Clin Pharmacokinet       Date:  2019-07       Impact factor: 6.447

2.  Nonadditivity in human microsomal drug metabolism revealed in a study with coumarin 152, a polyspecific cytochrome P450 substrate.

Authors:  Bikash Dangi; Nadezhda Y Davydova; Nikita E Vavilov; Victor G Zgoda; Dmitri R Davydov
Journal:  Xenobiotica       Date:  2020-07-26       Impact factor: 1.908

3.  Heterologous Expression and Functional Characterization of Novel CYP2C9 Variants Identified in the Alaska Native People.

Authors:  Matthew G McDonald; Lindsay M Henderson; Sutapa Ray; Catherine K Yeung; Amanda L Johnson; John P Kowalski; Helmut Hanenberg; Constanze Wiek; Kenneth E Thummel; Allan E Rettie
Journal:  J Pharmacol Exp Ther       Date:  2020-05-18       Impact factor: 4.030

4.  Sources of Interindividual Variability.

Authors:  Yvonne S Lin; Kenneth E Thummel; Brice D Thompson; Rheem A Totah; Christi W Cho
Journal:  Methods Mol Biol       Date:  2021

5.  Toward a systems approach to the human cytochrome P450 ensemble: interactions between CYP2D6 and CYP2E1 and their functional consequences.

Authors:  Dmitri R Davydov; Nadezhda Y Davydova; John T Rodgers; Thomas H Rushmore; Jeffrey P Jones
Journal:  Biochem J       Date:  2017-10-10       Impact factor: 3.857

Review 6.  Assembling the P450 puzzle: on the sources of nonadditivity in drug metabolism.

Authors:  Dmitri R Davydov; Bhagwat Prasad
Journal:  Trends Pharmacol Sci       Date:  2021-09-30       Impact factor: 14.819

7.  Toward a systems approach to cytochrome P450 ensemble: interactions of CYP2E1 with other P450 species and their impact on CYP1A2.

Authors:  Nadezhda Y Davydova; Bikash Dangi; Marc A Maldonado; Nikita E Vavilov; Victor G Zgoda; Dmitri R Davydov
Journal:  Biochem J       Date:  2019-12-12       Impact factor: 3.857

8.  Expression of cytochrome P450 isozyme transcripts and activities in human livers.

Authors:  Jie Liu; Yuan-Fu Lu; J Christopher Corton; Curtis D Klaassen
Journal:  Xenobiotica       Date:  2020-12-28       Impact factor: 1.908

9.  Effects of alcohol-induced increase in CYP2E1 content in human liver microsomes on the activity and cooperativity of CYP3A4.

Authors:  Bikash Dangi; Nadezhda Y Davydova; Marc A Maldonado; Armina Abbasi; Nikita E Vavilov; Victor G Zgoda; Dmitri R Davydov
Journal:  Arch Biochem Biophys       Date:  2020-11-13       Impact factor: 4.013

Review 10.  Drug-Metabolizing Cytochrome P450 Enzymes Have Multifarious Influences on Treatment Outcomes.

Authors:  Yurong Song; Chenxi Li; Guangzhi Liu; Rui Liu; Youwen Chen; Wen Li; Zhiwen Cao; Baosheng Zhao; Cheng Lu; Yuanyan Liu
Journal:  Clin Pharmacokinet       Date:  2021-03-16       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.